Cost‐effectiveness of a novel hypoglycaemia programme: The ‘HARPdoc vs BGAT’ RCT

Healey, A. orcid.org/0000-0003-2013-3161, Soukup, T. orcid.org/0000-0003-0203-7264, Sevdalis, N. orcid.org/0000-0001-7560-8924 et al. (13 more authors) (2024) Cost‐effectiveness of a novel hypoglycaemia programme: The ‘HARPdoc vs BGAT’ RCT. Diabetic Medicine, 41 (6). e15304. ISSN 0742-3071

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited: https://creativecommons.org/licenses/by/4.0/

Keywords: cost-effectiveness; health economics; hypoglycaemia; quality of life; randomised controlled trial; service utilization; type 1 diabetes
Dates:
  • Published: June 2024
  • Published (online): 29 February 2024
  • Accepted: 27 January 2024
  • Submitted: 9 November 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 08 Mar 2024 10:43
Last Modified: 08 Nov 2024 13:21
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1111/dme.15304
Open Archives Initiative ID (OAI ID):

Export

Statistics